Evaluation of four commercial systems for identification of medically important yeasts
- 1 April 1993
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 12 (4) , 255-260
- https://doi.org/10.1007/bf01967255
Abstract
Four commercially available systems for identification of yeasts were evaluated using 178 clinical isolates and seven reference strains previously identified by a conventional method. After 72 h of incubation, the rate of correct identification was 86.5 % with API20C Aux, 86 % with Auxacolor, 68 % with Mycotube and 51.1 % with Candifast. When considering only the reference strains included in the manufacturers' databases, the identification rate was 90 %, 91 %, 87 % and 61.2 % respectively. Although the results at 72 h obtained with API20C Aux and Auxacolor were similar, Auxacolor led to more rapid identification of the strains, 67.9 % versus 14.6 % being identified at 24h and 80.9 % versus 64 % being identified at 48 h.Keywords
This publication has 14 references indexed in Scilit:
- Candida Species: Emerging Hospital Bloodstream PathogensInfection Control & Hospital Epidemiology, 1991
- Collaborative investigation of variables in susceptibility testing of yeastsAntimicrobial Agents and Chemotherapy, 1990
- Emerging fungal pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Disseminated Infection with Trichosporon beigeliiClinical Infectious Diseases, 1987
- Mycoses Caused by Candida lusitaniaeClinical Infectious Diseases, 1987
- Candida lusitaniaeThe Pediatric Infectious Disease Journal, 1987
- Trichosporon beigelii infection: a review.1986
- Iricnosporon beigelii Infection: A ReviewClinical Infectious Diseases, 1986
- Evaluation of the new Mycotube Test-Kit for yeast identificationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a HumanAntimicrobial Agents and Chemotherapy, 1979